Bringing together key players in the antimalarial drug discovery fields
CRIMALDDI (Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives) would like to take this opportunity to invite you to be a part of its online discussion board and welcomes input and ideas from the wider malaria scientific community.
There will be plenty of opportunities for participation in the process as they set various questions for the community to give input and discuss. They would encourage anyone (scientists or implementers) to participate by adding comments and joining the discussions.
Please pass on this message to your colleagues so that we can have the maximum involvement of the malaria community in the work of the Consortium.
Visit the discussion forum now!
Background on CRIMALDDI
The CRIMALDDI project (Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives) is led by the Liverpool School of Tropical Medicine (LSTM) and brings together key players in the antimalarial drug discovery fields including the World Health Organization, the Medicines for Malaria Venture (MMV) and leading research organisations across Europe.
Antimalarial drug research and development (R&D) programmes are in operation across Europe and throughout the world, but too often these initiatives are uncoordinated and time and money is spent going over old ground. CRIMALDDI is addressing this by assessing research in Europe and internationally. It will develop a prioritised roadmap for antimalarial drug discovery efforts in Europe and a 5-year action plan to deliver on this roadmap. An expert advisory group provides external validation and ensures that the plans are practical and appropriate. CRIMALDDI will also seek to formulate strategies to ensure better co-ordination of R&D, remove barriers to drug development and facilitate the dissemination of results.